Mode
Text Size
Log in / Sign up

Outcomes of acute myocardial infarction patients with supranormal versus normal or reduced left ventricular ejection fractionWhen a Heart Pumps Too Well After a Heart Attack

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that main results and safety data were not reported for this cohort of AMI patients with supranormal LVEF.

This study utilized a large Korean nationwide cohort comprising 27,903 patients diagnosed with acute myocardial infarction (AMI) between November 2011 and June 2020. The population was stratified into four distinct groups based on left ventricular ejection fraction (LVEF): supranormal (≥65%), normal (50–64%), mid-range (40–49%), and reduced. The primary comparator group consisted of AMI patients with normal, mid-range, or reduced LVEF values.

The provided evidence explicitly states that main results were not reported within the available data. Furthermore, specific details regarding the primary outcome, secondary outcomes, follow-up duration, and adverse event profiles were not included in the input. Therefore, no quantitative data on mortality, reinfarction, or other clinical endpoints can be presented.

Safety and tolerability data, including adverse events, serious adverse events, discontinuations, and general tolerability, were not reported. The study is characterized as real-world evidence, yet the input notes that evidence on outcomes for patients with AMI and supranormal LVEF is currently lacking. This gap in the literature limits the ability to confirm whether supranormal LVEF confers a distinct prognostic advantage or disadvantage in this specific cohort.

Due to the absence of reported main results and the acknowledged lack of existing real-world evidence for this specific subgroup, the practice relevance remains undefined. Clinicians should interpret these findings with caution, recognizing that the data does not currently support specific recommendations for patients with supranormal LVEF following AMI.

The number that seems too good

You survive a heart attack. Weeks later, the cardiologist reads your ultrasound and says your heart is pumping at 70 percent.

That sounds great. Most people assume higher is better.

But new research is asking a careful question — is there such a thing as pumping too hard?

Doctors measure the heart's strength with something called ejection fraction, or EF. It's the share of blood the left lower chamber squeezes out with each beat.

A normal EF is between 50 and 64 percent. Below 40 percent is considered reduced — a red flag after a heart attack.

Above 65 percent is called supranormal, or "snLVEF" in the study. Until recently, doctors barely gave this group a second look.

The old thinking, and the shift

For decades, cardiology ran on a simple rule. Lower pumping equals worse outcomes. Higher pumping equals better outcomes.

Studies poured into the "reduced EF" group because those patients clearly needed help. The supranormal group got ignored.

But here's the shift. In other heart conditions — not heart attacks — very high EF has been linked to unexpected problems. Things like stiff heart muscle, odd rhythms, and higher death rates.

So what happens when you apply the same question to heart attack survivors?

How the heart "pumps too hard"

Think of the heart as a water balloon you squeeze.

A weak squeeze leaves water behind. That's reduced EF.

A normal squeeze empties most of the balloon. Good.

A very hard squeeze empties the balloon almost completely — but if the balloon is small and stiff to begin with, that "great" number may actually mean the heart is compensating for a problem hiding underneath.

In other words, a sky-high EF could be the sign of a heart that's too small, too stiff, or working too hard to keep up.

The study in plain terms

Researchers pulled records from the Korean nationwide heart attack registry. They gathered data on 27,903 people treated for acute myocardial infarction — the medical term for heart attack — between late 2011 and mid-2020.

They sorted patients into four groups based on pumping strength:

  • Supranormal: 65 percent or higher
  • Normal: 50 to 64 percent
  • Mid-range: 40 to 49 percent
  • Reduced: below 40 percent

Then they tracked what happened to each group.

What we know so far

The full results weren't available in the early abstract we reviewed. But the study's main goal is clear.

The researchers wanted to know whether the supranormal group really does better, worse, or about the same as the normal group — and whether that sky-high pumping number is hiding a risk.

This matters because every heart attack survivor gets an EF number. And those numbers shape decisions.

If a 70 percent EF actually carries unseen risks, cardiologists may need to rethink who needs closer follow-up.

Why this is getting attention

This pattern has already shown up in heart failure and high blood pressure research. People with very high EF sometimes had worse long-term health than those with middle-of-the-road EF.

Heart attack recovery has never been studied this way before. So this Korean registry is one of the first large, real-world looks at the supranormal group after a heart attack.

If you've had a heart attack and your EF came back in the high range, don't panic.

A high number is usually still better than a low number. This study does not flip that rule.

But it does suggest that "higher is always better" may not be the whole story. If your cardiologist recommends close follow-up, extra tests, or ongoing medication even with a strong EF, there's a reason.

Ask your doctor what your number means for you specifically. Your age, other conditions, and the size of your heart attack all factor in.

The honest limits

This was a retrospective study. That means researchers looked back at old records rather than following patients in real time.

The abstract we reviewed was cut off before the main numbers. So we don't yet know exactly how much worse — or better — the supranormal group fared.

And registries like this one include everyday patients with all kinds of other health problems. Sorting out what the high EF itself caused, versus what those other factors caused, is tricky.

Expect follow-up studies that dig deeper into the supranormal group. Scientists will want to know whether certain medications, exercise programs, or follow-up schedules change outcomes for these patients.

Don't expect guidelines to change overnight. Real-world practice shifts only after several studies agree.

In the meantime, your best bet is to keep showing up for cardiac rehab, take your medications, and stay in touch with your cardiology team — no matter what number sits on your echocardiogram report.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Background/aimsDespite cumulative evidence of superior outcomes for acute myocardial infarction (AMI) with normal left ventricular ejection fraction (LVEF) compared to those for AMI with reduced LVEF, real-world evidence on outcomes of patients with AMI and supranormal LVEF (snLVEF) is lacking. Therefore, this study aimed to evaluate the clinical outcomes of patients with AMI and snLVEF.MethodsA total of 27,903 patients with AMI were included from the Korean nationwide AMI cohort between November 2011 and June 2020 after excluding those with unmeasurable LVEF. Patients were classified into four groups according to LVEF: supranormal (≥65%), normal (50%–64%), mid-range (40%–49%), and reduced (
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.